Moleculin Biotech, Inc. Common Stock, Value, Issued
Moleculin Biotech, Inc. (MBRX) had Common Stock, Value, Issued of $7.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-13
- 2026-06-30: Common Stock, Value, Issued $7.00K.
- 2026-03-31: Common Stock, Value, Issued $5.00K.
- 2025-12-31: Common Stock, Value, Issued $3.00K.
- 2025-09-30: Common Stock, Value, Issued $49.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $7.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $5.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $3.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $49.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $30.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $14.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-18 | $3.00K 10-K · filed 2025-03-21 |
| 2024-09-30 | $3.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $3.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $2.00K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $33.00K 10-K · filed 2025-03-21 | |
| 2023-09-30 | $30.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $30.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $30.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $29.00K 10-K · filed 2024-03-22 | |
| 2022-09-30 | $29.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $29.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $29.00K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $29.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $29.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $29.00K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $28.00K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $69.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $62.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $60.00K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $53.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $46.00K 10-K · filed 2021-03-24 | |
| 2019-09-30 | $46.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $45.00K 10-Q · filed 2019-08-16 | |
| 2019-03-31 | $34.00K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $29.00K 10-K · filed 2020-03-19 | |
| 2018-09-30 | $27.00K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $27.00K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $26.00K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $21.00K 10-K · filed 2019-02-21 | |
| 2017-09-30 | $21.00K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $21.00K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $18.00K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $12.00K 10-K · filed 2018-03-28 | $12.16K 10-K · filed 2017-04-03 |
| 2016-09-30 | $12.05K 10-Q · filed 2016-11-21 | |
| 2016-06-30 | $11.26K 10-Q · filed 2016-11-21 | |
| 2016-03-31 | $6.79K 10-Q · filed 2016-06-16 | |
| 2015-12-31 | $6.66K 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |